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The soluble b-chymases mouse mast cell protease-1
(mMCP-1) and rat mast cell protease-II are predomi-
nantly expressed by intestinal mucosal mast cells (IM-
MCs) and may promote mucosal epithelial permeabil-
ity when released during intestinal allergic
hypersensitivity responses. To study the function of
these chymases, we generated mice with a homozy-
gous null mutation of the mMCP-1 gene and investi-
gated their response to infection with the intestinal
nematode Nippostrongylus brasiliensis. Whereas
mMCP-2, -4, and -5 were transcribed normally, there
was no transcription of the mMCP-1 gene in null
(2/2) mice, nor was mature mMCP-1 protein de-
tected in (2/2) jejunal mucosa. In contrast, levels of
mMCP-1 in wild-type (1/1) jejunal mucosa increased
200- to 350-fold from 0.66 mg mMCP-1/g wet weight in
uninfected mice to 129 and 229 mg/g wet weight on
days 8 and 10 of infection, respectively. The kinetics
of IMMC recruitment differed in 2/2 mice compared
with 1/1 controls on days 8 (P < 0.05) and 10 (P <
0.03) of infection. The IMMCs in infected 2/2 mice
stained poorly, if at all , for esterase with naphthol
AS-D chloroacetate compared with the intense stain-
ing observed in 1/1 controls. Ultrastructurally, the
prominent crystal intragranular structures that are
found in intraepithelial 1/1 IMMCs were absent from
2/2 IMMCs. These data show that disruption of the
mMCP-1 gene leads to profound histochemical and
ultrastructural changes in IMMC granules. (Am J
Pathol 1998, 153:491–504)
Intestinal mucosal mast cells (IMMCs) in the mouse are
distinguished from connective tissue mast cells (CTMCs)
by their predominantly intraepithelial localization and
unique fixation, by their histochemical and morphological
properties,1,2 and by their content of granule chy-
mases.1,3 Compared with other mammalian species, in-
cluding rat, sheep, and human, in which IMMCs are
relatively abundant and located in the lamina propria,4–6
IMMCs in mice are rare unless the animal has recently
harbored an intestinal nematode infection.1,3 At about the
time of the immunological expulsion of intestinal nema-
todes, there is substantial IMMC hyperplasia in murine
rodents and ruminants, as well as in other species, in-
cluding guinea pigs and gerbils.7,8 Hyperplasia of IM-
MCs has also been described in parasitized humans,9
and this type of response may be common to most mam-
malian species infested with nematodes, suggesting that
mast cells play a role in the extensive immunopathology
associated with intestinal nematodiasis.4,6
The hyperplasia and differentiation of IMMCs in re-
sponse to nematode infection is highly T-cell dependent,
and in murine rodents the ligand for c-kit, stem cell factor
(SCF), plays a key role in nematode-induced IMMC hy-
perplasia.10,11 Studies of parasitized rodents and sheep
have shown that IMMCs express soluble chymases that,
at about the time of the immunological expulsion of the
parasites, are secreted systemically into the bloodstream
and across the epithelium into the gut lumen.4 It is likely,
therefore, that granule chymases serve a functional role
in the protective response against gastrointestinal hel-
minth parasites. It is probably significant that .95% of
IMMCs in mice, and 40 to 50% of IMMCs in rats and
sheep, are located intraepithelially at the time of worm
elimination, because this would facilitate the access of
secreted chymases to the epithelial tight junctions4,12
and, possibly, to protease-activated receptors on the
enterocytes.13 There are, therefore, several mechanisms by
which IMMCs could alter epithelial function or integrity.
In rodents, the soluble b-chymases mouse mast cell
protease-1 (mMCP-1) and rat mast cell protease-II
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(rMCP-II) are abundantly expressed by IMMCs; are 74%
homologous at the amino acid level with net charges of
13 and 14, respectively14; and probably, therefore,
serve similar functions in vivo. The introduction of rMCP-II
into the perfused mesenteric artery of normal rats is as-
sociated with rapid development of intestinal mucosal
permeability.12 Similarly, systemic challenge with worm
antigen in rats sensitized by previous infection is associ-
ated with immediate and substantial release of rMCP-II
into the gut lumen and is accompanied by the transloca-
tion of plasma proteins across the intestinal epithelium.12
One of the major functions of these soluble b-chymases
is, therefore, to promote mucosal permeability in intesti-
nal allergic hypersensitivity reactions. However, it is also
likely that these abundant chymases serve other as yet
undefined functions. To address the functions of these
b-chymases more directly, we have used a targeting
strategy to generate mice lacking a functional mMCP-1
gene. Our results suggest that mMCP-1 plays a role in the
regulation of mast cell hyperplasia during nematode in-
fection and that its absence is associated with altered
size and internal structure of IMMC granules.
Materials and Methods
Construction of the mMCP-1 Targeting Vector
Using a full-length cDNA clone for mMCP-1 as a tem-
plate, a 100-bp probe was generated by polymerase
chain reaction (PCR) using primers that amplified a
100-bp region of the 59-untranslated region of mMCP-1 to
minimize the possibility of inadvertently isolating clones
from related protease genes.14 The probe was labeled
with digoxigenin (DIG) (Boehringer Mannheim, Lewes,
UK) in the PCR and used to isolate a full-length genomic
clone from a 129-strain mouse genomic l-library. This
clone was mapped and consisted of a 15-kb fragment
containing the mMCP-1 gene with extensive 59 and 39
flanking regions. A combination of DNA sequencing and
Southern blotting was used to confirm the identity of the
mMCP-1 clone. A 4.35-kb PvuII-HindIII and 3.9-kb Hin-
dIII-SalI restriction fragment incorporating the 59 and 39
flanking regions of the mMCP-1 gene was cloned into
pSP72 (Promega, Southampton, UK). A 4.8-kb fragment
containing all five exons of the mMCP-1 gene itself was
replaced in the above construct by a neo gene driven by
a human b-actin promoter and including an SV40 poly-
adenylation signal,15 to form the targeting vector.
Electroporation, Selection and Screening of
Embryonic Stem Cells, Blastocyst Injection, and
Production of Chimeras
The targeting vector was linearized by HindIII digest and
electroporated into 129 strain mouse embryonic stem
(ES) cells. Linearized DNA was added to 9.0 3 107 E14
Tg2A ES cells and exposed to a 0.8-kV 3.0-mF pulse and
plated out at 5 3 106 cells/100-cm Petri dish. Cells were
subjected to selection by G418 (175 mg/ml) on days 1, 3,
5, 7, and 9. Resistant clones containing the correct tar-
geting event were identified by Southern blotting using
two external screening probes (Figure 1A). After homol-
ogous recombination an endogenous EcoRI fragment
was converted from a 12-kb fragment to a 10.2-kb frag-
ment detected by the first probe (A) because of the
substitution of the five exons of mMCP-1 with the neo
cassette. The replacement event was confirmed using a
second probe (B) to detect generation of a 9.1-kb EcoRI
fragment. All confirmed clones were analyzed with a third
probe derived from the neo cassette to ensure single
integration events. The frequency of correctly targeted
clones was 5 out of 192 (2.6%). Targeted ES cell clones
were separately microinjected into blastocysts collected
3.5 days postcoitum from C57BL/6 mice and implanted
into C57BL/6 3 CBA pseudopregnant foster females 2.5
days postcoitum. ES cell-derived progeny identified by
coat color were screened by Southern blot analysis and
long-template PCR (LT-PCR) to detect the correct target-
ing event, and targeted progeny were backcrossed with
MF-1 strain mice.
Screening Progeny by LT-PCR
Genomic DNA was prepared by phenol/chloroform ex-
traction16 and amplified using LT-PCR (Boehringer
Mannheim). The positions of the primers used are indi-
cated in Figure 1A. Two pairs of oligonucleotide primers
were used: primers P1 and P2, which amplify the wild-
type mMCP-1 allele to give a product of 5 kb, and primers
P1 and P3, which amplify the correctly targeted allele
to give a product of 7.3 kb. Primer sequences were
as follows: 59-TGAGCAGGTGGAGACTCCTGATAGT-39
(P1), 59-AGCTCTCTGGTACTCTTTGGTTCA-39 (P2), and
59-TGCATTAATGAATCGGCCAACGCGC-39 (P3).14 Re-
actions were carried out in 50-ml volumes in thin-walled
0.2-ml tubes (Perkin Elmer MicroAmp; Perkin Elmer
Corp., Norwalk, CT) containing 20- to 100-ng template
DNA, 350 mmol/L deoxynucleotide triphosphates, 300
nmol/L of each primer, 13 Boehringer Mannheim Expand
PCR buffer (50 mmol/L Tris-HCl pH 9.2, 16 mmol/L
(NH4)2SO4, 1.75 mmol/L MgCl2), and 3.5 U Taq/Pwo
enxyme mix. After an initial denaturation step for 2 min-
utes at 94°C, the DNA was amplified for 10 seconds at
94°C, 30 seconds at 65°C, and 4 minutes at 68°C for 10
thermocycles, followed by 10 seconds at 94°C, 30 sec-
onds at 65°C, and 4 minutes at 68°C, with the latter step
extended by 20 seconds at each cycle for 20 thermo-
cycles and a final elongation step of 7 minutes at 68°C.
The PCR products were analyzed on 1% agarose gels.
The level of detection was increased and the authen-
ticity of the PCR products was confirmed by Southern
hybridization with a DIG (Boehringer Mannheim)-labeled
cDNA probe specific for a region within probe B, 39 of the
targeted construct and common to LT-PCR products
from both alleles, without including LT-PCR primer se-
quences. The cDNA probe was amplified and DIG la-
beled by PCR of a 147-bp fragment using a probe B
cDNA clone as a template and substitution of de-
oxynucleotide triphosphate with DIG-11-deoxyuridine
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triphosphate labeling mixture in the PCR (Boehringer
Mannheim). Primers were 59-ACATGCATAAGAATAAA
CACTGTGG-39and59-ACAGGTTTAATGGCTTCCAGAAA
GG-39. For Southern detection the DIG-labeled probe
was denatured at 95°C (10 minutes), chilled on ice, and
hybridized at 20 ng/ml in a total volume of 10 ml Rapidhyb
(Amersham, Rainham, UK) hybridization buffer/membrane.
After hybridization for 3 hours, membranes were washed at
high stringency (65°C in 0.13 standard saline citrate/0.1%
sodium dodecyl sulfate). Hybridized probe was detected
with anti-DIG alkaline phosphatase antibody using colori-
metric detection with 5-bromo-4-chloro-3-indolyl phos-
phate/nitroblue tetrazolium. The LT-PCR products de-
tected by Southern hybridization from a typical wild-type
(mMCP-11/1) homozygote (mMCP-12/2) and heterozy-
gote (mMCP-11/2) mouse are shown in Figure 1B.
Parasite Infections and Tissue Preparation
The mouse-adapted strain of Nippostrongylus brasiliensis
(generously supplied by Dr. J. Urban) was maintained by
alternate passage through BALB/c and Swiss White
strains of mice and charcoal cultures as described pre-
viously.17 Null (mMCP-12/2) mice and MF-1 (mMCP-
11/1) controls were infected with 500 N. brasiliensis L3,
and infection was monitored by fecal egg counts. Mice
were killed by exsanguination under terminal anesthesia,
and small (,1 cm) samples of jejunum were immediately
snap frozen in liquid nitrogen for RNA analysis, and on
dry ice for immunoassay of mMCP-1, and stored at
270°C before extraction. Two separate but adjacent sam-
ples of jejunum approximately 6 to 8 cm long were taken
2 to 3 cm distal to the ligament of Trietz, and worms were
counted in situ using a dissecting microscope after open-
ing and flattening the intestine onto stiff blotting paper.
After counting, the jejunum was gently lifted off the paper
and rolled with villi outermost onto the tip of a plastic
pipette (pastette) and immediately transferred to Car-
noy’s fluid or 4% paraformaldehyde dissolved in phos-
phate-buffered saline (PF/PBS) as described previous-
ly.17,18 Samples of ear pinnae from the same mice were
also snap frozen or fixed in Carnoy’s fluid or PF/PBS. After
fixation for 6 hours in PF/PBS or overnight in Carnoy’s fluid,
the tissues were transferred to 70% ethanol and stored at
4°C for a minimum of 24 hours before trimming, processing,
and embedding in paraffin wax. Similar procedures for col-
lecting jejunum were followed for uninfected (control) mice.
Detection of Transcripts by Reverse
Transcription-PCR
Total RNA was extracted from snap-frozen ear pinnae
and jejunum by maceration in 1 to 2 ml of Tri-Reagent
Figure 1. A: The targeting construct. Top: Wild-type allele; genomic structure and partial restriction map of the mMCP-1 gene. Exons are represented by solid
boxes, and the length of the diagnostic EcoRI restriction fragments (solid lines) and probes used for Southern blot analysis are shown, in addition to primers used
for LT-PCR and expected sizes of the PCR products (dotted lines). Middle: Targeting vector with homology regions of 3.9 kb on the 59 side and 4.2 kb on the 39
side of the neo gene and pSP72 vector. Bottom: Targeted allele; predicted structure of the targeted mMCP-1 locus. All five exons have been deleted and replaced
by the neo gene driven by its own promoter. Again, the diagnostic EcoRI restriction fragments and probes used for Southern blot analysis of correct recombinants
are shown. B: Screening progeny by LT-PCR. Example of a Southern blot of LT-PCR products generated from genomic tail-snip DNA of MF1 mice derived from
a heterozygote cross. Primers P1 and P2 amplify wild-type alleles to give a product of 5 kb, whereas primers P1 and P3 amplify targeted alleles to give a product
of 7.3 kb; details can be found in (A). The PCR products were hybridized with the DIG-labeled 147-bp region within probe B. PCR products are shown from a
wild-type (1/1), a heterozygote (1/2), and a homozygote (2/2) mouse.
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(Sigma, Poole, UK) with a mortar and pestle precooled
to 270°C as described previously.18 The quantity and
quality of the total RNA was determined by measurement
of the absorbance at 260/280 nm in a Beckman DU 650
spectrophotometer.
Because mast cell-associated heparin can copurify
with RNA and is known to inhibit the PCR reaction, RNA
samples were treated with heparinase before reverse
transcription (RT).19 Aliquots of 4 mg RNA were incu-
bated with 4 U heparinase I (Sigma) in 5 mmol/L Tris-HCl
pH 7.5, 1 mmol/L CaCl2, and 40 U RNase inhibitor (Pro-
mega) in a total volume of 40 ml for 2 hours at 25°C. Serial
dilutions of the heparinase-treated samples were reverse
transcribed in 20-ml volumes containing 1, 0.1, or 0.01 mg
RNA, 1 mmol/L deoxynucleotide triphosphates, 20 U
RNase inhibitor, 2.5 mmol/L (dT) is oligonucleotide prim-
ers, 13 RT buffer, and 2.5 mmol/L MgCl2; 50 U of avian
myeloblastosis virus reverse transcriptase reaction was
diluted to 100 ml, and 10 ml were used for each PCR
reaction. The cDNA was amplified for 1 minute at 94°C, 2
minutes at 63°C, and 3 minutes at 72°C for 30 thermo-
cycles in 50-ml volumes in thin-walled 0.2-ml tubes (Per-
kin Elmer MicroAmp) containing 250 mmol/L deoxynucle-
otide triphosphates, 250 nmol/L of each primer, 13
Boehringer Mannheim PCR buffer (10 mmol/L Tris-HCl,
50 mmol/L KCl, and 1.5 mmol/L MgCl2, pH 8.3) and 2.5 U
Taq DNA polymerase (Boehringer Mannheim). Oligonu-
cleotide primers used are detailed in Table 1. Five pairs
of oligonucleotide primers were used to identify transcrip-
tion of chymase genes commonly expressed in mouse
mast cells: mMCP-1, 2, 4, and 5.14,20,21,22,23,24 All prim-
ers were designed to span an intron to ensure that
genomic DNA was distinguishable from cDNA PCR prod-
ucts. In addition, oligonucleotide primers for SCF, tran-
scribed by jejunal epithelial cells25,26 and mouse car-
boxypeptidase A27 (Table 1), were used in some PCRs
(infected jejunum only). Primers for a 514-bp fragment
from mouse b-actin cDNA, 59-TGTGATGGTGGGAAT
GGGTCAG (59 primer) and 59-TTTGATGTCACGCAC
GATTTCC (purchased from Stratagene, Cambridge, UK),
were included in all PCR reactions as a control to elimi-
nate variations in the heparinase/RT reactions that could
affect the efficiency of subsequent PCR reactions. The
RNA concentrations 1, 0.1, and 0.01 mg RNA/20 ml in the
RT reaction (final amounts in PCR of 100, 10, and 1 ng)
were determined in initial pilot studies. PCRs for car-
boxypeptidase A and SCF were carried out at a single
RNA concentration of 10 ng/PCR reaction with the sole
purpose of detecting the presence or absence of these
transcripts. Controls included in the PCR reactions were
RNA only (no cDNA) and primers only (no target).
PCR products were separated on 1.2% agarose gels
and recorded with a charge-coupled device camera
linked to an image processor (Appligene, Warford, UK),
and the band intensities were analyzed using a densi-
tometry package (Quantiscan II for Windows 95; Biosoft,
Cambridge, UK). The intensity of each band was mea-
sured relative to the intensity of its corresponding b-actin
signal. The authenticity of the PCR products was con-
firmed by Southern hybridization using gene-specific oli-
gonucleotide probes, the sequences of which are shown
in Table 2. One hundred pmol of each oligonucleotide
probe was 39 end-labeled with DIG-dideoxyuridine
triphosphate using terminal transferase (Boerhinger
Mannheim) according to the manufacturer’s instructions.
Membranes were hybridized with DIG-labeled probes at
10 pmol/ml in a total volume of 10 ml of Rapidhyb (Am-
ersham) hybridization buffer/membrane for 3 hours at
40°C. Washing steps at high stringency, antibody incu-
bations, and visualization of bands with 5-bromo-4-
chloro-3-indolyl phosphate/nitroblue tetrazolium were
carried out as described in the section on LT-PCR
screening. All PCR products were of the expected sizes
for cDNA, and Southern blotting with gene-specific oligo-
Table 1. PCR Primers and Product Sizes
Gene Primer Sequence
Product size from
cDNA (bp)
mMCP-1* 59 59-GGAAAACTGGAGAGAAAGAACCTAC 460
39 59-GACAGCTGGGGACAGAATGGGG
mMCP-2† 59 59-ATTTCATTGCCTAGTTCCTCTGAC 525
39 59-CAGGATGAGAACAGGCTGGGAT
mMCP-4‡ 59 59-GTAATTCCTCTGCCTCGTCCTTC 454
39 59-GGACAGGATGGACACATGCTTT
mMCP-5§ 59 59-GGCAGAACAAACGTGAATGAGCC 418
39 59-AAGAACCTTCTGGAAGCTCAGGG
Carboxypeptidase A¶ 59 59-ACACAGGATCGAATGTGGAG 689
39 59-TAATGCAGGACTTCATGAGC
SCF\ 59 59-GCCTTTCCTTATGAAGAAGA 575
39 59-TGCAACAGGGGGTAACATAAATGG
Primers designed using cDNA sequence from *Ghildyal et al,10 †Serafin et al,21 ‡Serafin et al,22 and §McNeil et al.23
¶Primer sequences from Tsai et al.19
\Primer sequences from Zaheer et al.24
Table 2. Oligonucleotide Probes for PCR Products
PCR product Probe sequence
mMCP-1 59-AAGGCAGGCTGCACATAG
mMCP-2 59-CTCAGAGGTACCAGATGA
mMCP-4 59-CCCAAGGGTTATTAGAAGAGCTC
mMCP-5 59-TACAGACAGGCCAGATCA
Carboxypeptidase A 59-AACTCCACCTGCATTGGCACT
SCF 59-CAAACTTGGATTATCACTTGCAT
Oligonucleotide probes were designed using the cDNA sequences
indicated in Table 1.
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nucleotide probes confirmed their identity. No bands
were detected in the RNA-only and no-target controls.
Contamination from genomic DNA (indicated by a high-
er-kb band of 800 to 1000 bp for the proteinase genes)
was negligible (,5% of cDNA product in samples con-
taining higher RNA concentrations).
Detection of Mast Cells by Histochemistry
Mast cells were detected after staining 4 mm-thick sec-
tions from paraffin wax-embedded Carnoy’s fixed tissue
overnight in 0.5% toluidine blue (Merck, Poole, UK) and
0.5 mol/L HCl pH 0.5,1 followed by counterstaining with
1% eosin in 70% ethanol, or by staining paraformalde-
hyde fixed-tissue sections for esterase in Fast Garnet
GBC salt and naphthol AS-D chloroacetate (Sigma).28
Sections were mounted using Vectashield (Vector Labo-
ratories, Bretton, UK).
Detection of mMCP-1 and Other Chymases
by Immunohistochemistry
Immunodetection of mMCP-1 was carried out on parafor-
maldehyde-fixed tissues using the monoclonal antibody
(mAb) RF6.1 as described in detail.17 Chymases were
detected using a broad-specificity polyclonal sheep anti-
mMCP-1 antibody (Sh a-mMCP-1), which was affinity
purified on mMCP-1 sepharose and conjugated to biotin
according to the manufacturer’s instructions (EZ-link
Sulfo-NHS-LC-Biotin, Pierce, Rockford, IL). Rat immuno-
globulin G1 (10 mg/ml; Serotec) was used as a negative
control for mAb RF6.1 and biotinylated sheep immuno-
globulin G (Sigma) for Sh amMCP-1. Detection was with
avidin/peroxidase (jejunum) and avidin/alkaline phospha-
tase (ear pinnae) (Vectastain ABC Kit, Vector Laborato-
ries). Sections were counterstained with hematoxylin.
Enumeration of Mast Cells and
Statistical Analysis
Tissue sections stained for mMCP-1 (mAb RF6.1), chy-
mases (Sh amMCP-1), and esterase were counted at
3250 magnification, whereas toluidine blue-stained sec-
tions were counted at 3500. Positively stained mast cells
were counted in 50 villus crypt units (VCUs) in jejunal
sections, and the results are expressed as IMMCs/
VCU.29 Mast cells in longitudinal sections of ear pinnae
were counted in 20 adjacent fields (4.8 mm2 total area).
Median cell counts were compared using the nonpara-
metric Mann-Whitney test (Minitab) with significance lev-
els of P , 0.05.
Electron Microscopy
Samples of jejunum (;1 mm3) were immersed in 2.5%
glutaraldehyde (pH 7.4) in sodium cacodylate for 4 to 6
hours at room temperature and processed as described
by Friend et al.3 Samples were taken from two 1/1 and
two 2/2 mice on each of days 8 and 10 postinfection.
Ultrathin sections were stained with uranyl acetate and
lead citrate. For each of the four groups, 17 to 40 mast
cells (100 to 200 granules) were photographed, and
numbers per cell and sizes of individual granules (max-
imum diameter in mm) were recorded, as was the pres-
ence of intragranular structures such as crystalline bod-
ies. In cases in which granules were of uneven shape, the
mean of the two longest diameters was taken. The gran-
ule sizes were compared using x2 analysis with signifi-
cance levels of P , 0.05.
Quantification of mMCP-1 by Enzyme-Linked
Immunosorbent Assay and Detection of mMCP-
1 and Other Chymases by Western Blotting
mMCP-1 concentrations were assayed using the RF6.1
monoclonal-based enzyme-linked immunosorbent as-
say,17 and the presence of mMCP-1 and of related chy-
mases was determined by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis and Western blotting.17
Blots were blocked in Tris-buffered saline-Tween 80 and
probed with mAb RF 6.1 as described.17 For detection of
chymases, blots were blocked with 4% normal sheep
serum/Tris-buffered saline-Tween 80 before probing with
biotinylated Sh amMCP-1 (0.6 mg/ml) for 1 hour. Bands
were visualized using an avidin-biotin complex technique
(Vectastain ABC kit, Vector) followed by detection with
5-bromo-4-chloro-3-indolyl phosphate/nitroblue tetrazolium.
Results
Production of Chimeric and Germline
Mutant Mice
Two positive ES cell clones were separately microin-
jected into C57BL/6 blastocysts and implanted into
C57BL/6 3 CBA strain pseudopregnant foster females.
Both clones gave rise to chimeric males that were then
mated to MF1 females. ES cell-derived progeny identified
by coat color were screened by Southern blot analysis
and LT-PCR to detect germline transmission of the
mMCP-12 allele. Matings from one of the chimeras gave
germline transmission of the desired homologous recom-
bination event. When MF-1/129 progeny that were het-
erozygous for the deleted mMCP-1 allele (mMCP-1 1/2)
were intercrossed, they produced the expected ratios
(2:1:1) of heterozygous (mMCP-1 1/2), wild-type
(mMCP-11/1), and homozygous (mMCP-12/2) mutant
progeny (Figure 1B). These mice developed normally
and showed normal fertility.
IMMC Kinetics Are Altered during N. brasiliensis
Infection in mMCP-12/2 Mice
Infection Kinetics
Groups of 20 2/2 and 20 1/1 mice were infected with
500 N. brasiliensis infective larvae (L3). Worm burdens
were examined on day 8 (n 5 10) and on day 10 (n 5 10)
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when f.e.cs had declined. Maximum (n 5 10) occurred
on day 7 when there was a fivefold difference between
the two groups (Figure 2). This was not statistically sig-
nificant because of sample variability with zero fecal egg
counts in two mMCP-12/2 mice and one mMCP-11/1
control. Recovery of worms from the infected mice again
showed a trend toward greater worm burdens in the 2/2
mice with an approximately twofold difference on day 8
(Table 3). When geometric means (log10(x 1 1)) were
compared, significantly more worms (P , 0.05, Student’s
t-test) were found in 2/2 mice on day 8. Differences were
not significant on day 10 (Table 3).
Mast Cell Counts
In uninfected control mice, toluidine blue-stained IM-
MCs were rare, with median values of 0.03 IMMCs/VCU
for both mMCP-12/2 (range, 0 to 0.07) and mMCP-11/1
(range, 0 to 0.04) groups of mice (n 5 8 for both groups).
The few cells that were detected were intraepithelial in
both groups. Eight days after infection, the median values
were 10.6 IMMCs/VCU in the 2/2 mice (n 5 10) and 15
IMMCs/VCU in the 1/1 group (n 5 10; P , 0.05) (Figure
3). However, by day 10, there was a 2.5-fold increase in
the IMMC population (median, 25.7 IMMCs/VCU; range,
15.2 to 65.3) in 2/2 mice (n 5 10), which was signifi-
cantly (P , 0.03) more abundant than in 1/1 mice (median,
19.1 IMMCs/VCU; range, 7.3 to 44) (n 5 10) (Figure 3).
IMMCs in 2/2 and 1/1 Mice Are
Morphologically Distinct
Light Microscopy
After infection, IMMCs in 2/2 mice were less strongly
stained with toluidine blue than were their counterparts in
1/1 MF-1 mice. This appeared to be due to the smaller
size and reduced staining intensity of the granules (Fig-
ure 4, A and B). In uninfected controls, the few toluidine
blue-positive IMMCs were weakly stained in both 2/2
and 1/1 mice, and it was not possible to detect obvious
morphological differences between the two groups.
When 1-mm sections of jejunum from infected 2/2 and
Figure 2. Fecal egg counts in 1/1 and 2/2 mice infected with N. brasil-
iensis are shown as geometric means (6SE).
Table 3. Worm Burden Data in mMCP-1 2/2 and 1/1 Mice on Days 8 and 10 of Infection with N. brasiliensis
n
mMCP-11/1 mMCP-12/2
Mean (6 SE) log10(x 1 1) 6 SE Mean (6 SE) log10(x 1 1) 6 SE
Day 8 10 40 (17) 1.06 6 (0.27) (A) 73 (14) 1.73 6 (0.15)(B)
Day 10 10 2 (1) 0.28 6 0.12 19 (11) 0.62 6 0.31
A versus B significant at P , 0.05 (Student’s two-sample t-test).
Figure 3. The mean IMMC counts (cells/VCU) in 2/2 and 1/1 mice 8 days
(top) and 10 days (bottom) after infection are plotted to show cells containing
esterase, mMCP-1, or other chymases in paraformaldehyde-fixed jejunum (as
indicated). Toluidine blue (Tol. blue) staining of IMMCs is in Carnoy-fixed
jejunum. SEs are indicated by vertical bars. The P values shown above each
data set were calculated using the Mann-Whitney test.
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1/1 mice were compared, the granules in 2/2 IMMCs
were uniformly round (Figure 4B, inset), whereas those in
1/1 IMMCs were irregularly shaped (Figure 4A, inset).
Because of the sparcity of IMMCs in uninfected mice, no
attempt was made to compare them morphologically,
and all of the studies described below are from infected
mice. The differences observed by light microscopy were
more obvious ultrastructurally.
Ultrastructure
Crystalline bodies were abundant in the 1/1 IMMCs
(Figure 5, A and B), being identified in 31 of 36 and 14 of
17 cells on days 8 and 10 of infection, respectively; at
least 50% of all of the 1/1 granules contained these
structures, whereas the majority of the remaining gran-
ules were uniformly dense but were irregularly shaped. In
Figure 4. Light micrographs showing staining with toluidine blue (A and B), esterase (C and D), and immunoperoxidase detection for anti-mMCP-1 mAb (mAb
RF 6.1) (E and F) and polyclonal sheep anti-mMCP-1 (G and H). All tissues were taken on day 8 of infection. Note the intense staining of 1/1 IMMCs (A, C,
E, and G) with each of the four techniques and the absence of mAb RF 6.1 detection (F) and the very weak esterase (D) and polyclonal (H) staining of 2/2 IMMCs.
The higher-resolution pictures of individual mast cells in 1-mm sections of plastic-embedded tissues show that the IMMC granules in 1/1 jejunum (A, inset) are
more irregular in shape and larger than those in the 2/2 IMMCs (B, inset). The mast cells in ear pinna from 2/2 mice stain intensely with toluidine blue (I) and
are strongly esterase positive (J). Polyclonal antibody labeling of mast cells in ear pinna using an avidin alkaline phosphatase conjugate (K) contrasts with the
complete absence of mMCP-1 mAb staining (L). Magnifications: A, B, E, F, G, and H, 3500; C, D, and I to L, 3350; A and B insets, 31000.
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Figure 5. Electron micrographs showing typical IMMCs and IMMC granules from 1/1 (A and B) and 2/2 (C, D, and E) jejunal sections, from day 8 postinfection.
The crystalline bodies, clearly visible in electron micrographs (A) and (B), are only found in 1/1 IMMCs, whereas granules containing internal divisions (C, D,
and E) were exclusive to the 2/2 IMMCs. Magnifications: B and E, 314,250; A, C, and D, 332,000.
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contrast, no crystalline structures were observed in any of
the 2/2 granules that were of a more regular, oval shape
(Figure 5, C, D, and E) in the 2/2 mice on both days of
infection. Approximately 30% of the granules contained
unusual intragranular divisions with a dense, unstruc-
tured core separated into two or more segments by a
lighter stippled matrix (Figure 5, C, D, and E). These
intragranular divisions were present in 10 of 28 2/2
IMMCs on day 8 and in 16 of 47 IMMCs on day 10.
Furthermore, 2/2 IMMCs had significantly smaller gran-
ules than 1/1 IMMCs (P , 0.0001) according to x2
analysis (Figure 6), with median diameters of 0.5 and 1.0
mm, respectively, on day 8. The range of granule sizes in
both groups on day 10 was more widely dispersed. An
apparent shift in granule size from small on day 8 to
larger (1–1.6 mm in diameter) in 2/2 mice on day 10 was
obvious. Conversely, a higher proportion of 1/1 granules
were in the 0.4 to 0.8-mm range on day 10, so they were
significantly smaller than in 2/2 IMMCs (P , 0.0001)
(Figure 6).
IMMC Granules in 2/2 Mice Have Reduced
Esterase Activity
A property common to IMMCs and to CTMCs in rodents
is that they stain intensely with the esterase substrate
naphthol AS-D chloroacetate.3,28 This is true for IMMCs in
normal and in parasitized intestine,28 and the numbers of
cells detected using this substrate when compared with
toluidine blue staining28 or with immunohistochemical de-
tection of b-chymases17 are highly correlated. Therefore,
the intensity of staining for serine esterase was compared
in paraformaldehyde-fixed intestines from normal and
parasitized 1/1 and 2/2 mice. In uninfected controls,
esterase staining was sufficiently strong to detect IMMCs
in both groups (n 5 8) (median, 0.09 IMMC/VCU in 1/1
mice (range, 0.04 to 0.1); median, 0.05 IMMCs/VCU in
2/2 mice (range, 0.03–0.1)). In contrast, the median
values for esterase-stained 2/2 IMMCs on days 8 and 10
of infection were 1.2 IMMCs/VCU (range, 0.6 to 11.3) and
4.4 IMMCs/VCU (range, 0.3 to 34.6), respectively,
against comparable values for toluidine blue staining of
10.6 (P , 0.0025) and 25.7 IMMCs/VCU (P , 0.005)
(Figure 3). In contrast, the esterase staining and toluidine
blue staining in the 1/1 controls were not significantly
different (Figure 3). The IMMCs in all infected 1/1 mice
were intensely esterase-positive (Figure 4C) when com-
pared with those in the infected 2/2 mice (Figure 4D),
and there were significantly more esterase-positive IM-
MCs in 1/1 mice than in the 2/2 groups (P , 0.006 on
day 8; P , 0.03 on day 10) (Figure 3). Overall, therefore,
esterase staining was substantially depleted in targeted
mice infected with N. brasiliensis.
IMMCs from 2/2 Mice Lack Mature
mMCP-1 Protein
Immunohistochemical analysis of the content of mMCP-1
in paraformaldehyde-fixed normal and parasitized jeju-
num using a rat monoclonal anti-mMCP-1 antibody (RF
6.1) established that no staining was detectable in 2/2
groups (Figure 4D). Immunostaining was, however,
readily detected in all 1/1 mice (Figure 4E), and cell
counts established that the numbers of cells counted for
each group were not significantly different from the
counts obtained for esterase-positive and toluidine blue-
positive IMMCs (Figure 3). The same was true for unin-
fected 1/1 and 2/2 mice, with median values of 0.03
(n 5 8) and 0 (n 5 8) IMMCs/VCU, respectively. These
results clearly show that 2/2 mice fail to express mature
mMCP-1 protein, and that the majority of IMMCs in nor-
mal and parasitized 1/1 mice contain this enzyme.
The lack of expression of mMCP-1 by IMMCs was
further confirmed when homogenates of jejunum were
assayed for their content of mMCP-1 by enzyme-linked
Figure 6. Plots of the frequency distribution of granule diameters (mm) from
electron micrographs of 1/1 and 2/2 IMMCs in jejunal sections from days
8 (A) and 10 (B) after N. brasiliensis infection. Granules were classified to the
nearest 0.1 mm, up to 2.0 mm (and over). In total, 132 granules (in 28 cells)
and 231 granules (in 47 cells) were counted from 2/2 IMMCs from days 8
and 10 postinfection, respectively. One hundred fifty-two granules (36 cells)
and 91 granules (17 cells) were counted from 1/1 IMMCs from days 8 and
10. - - - - - , the four size categories pooled for x2 analysis; overall P values
are indicated.
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immunosorbent assay. There was no detectable mMCP-1
in any of the 2/2 jejunal samples, whereas 1/1 mice had
jejunal levels of 129.4 6 18.1 mg/g wet weight of jejunal
homogenate on day 8 and 229.2 6 37.1 mg/g on day 10.
The overall increase in mMCP-1 in jejunal homogenates
was on the order of 200- to 350-fold in the wild-type 1/1
infected mice versus uninfected controls.
Western blots of jejunal homogenates from 2/2 and
1/1 mice, using mAb RF6.1, confirmed the absence of
mature mMCP-1 protein in 2/2 jejunum and the pres-
ence of several mMCP-1 glycoforms in 1/1 homoge-
nates (Figure 7). In contrast, no bands were visualized
with mAb RF 6.1 in homogenates of ear pinna (Figure 7).
When the polyclonal anti-mMCP-1 antibody was used,
several intensely stained bands were detected in the
25,000 to 33,000-molecular weight range in homoge-
nates from 1/1 jejunum. In jejunal homogenates from
infected 2/2 mice, an intensely stained band of molec-
ular weight approximately 28,000 d was present, as were
several higher-molecular weight, less intensely stained
bands (Figure 7). This result further confirms the absence
of mature mMCP-1 protein detectable with mAb RF6.1 in
mMCP-12/2 jejunum and demonstrates that the non-
cross-absorbed polyclonal anti-mMCP-1 antibody reacts
with mMCP-1 and with other putative chymases in in-
fected jejunum from mMCP-11/1 and mMCP-12/2
mice, respectively. The polyclonal anti-mMCP-1 antibody
failed to reveal any specific bands in homogenates of ear
pinna (not shown).
Immunohistochemical Detection of
Other Chymases
Previous studies have shown that the polyclonal antibod-
ies raised against mMCP-1 will, before they are cross-
absorbed against rat mast cell protease-1, cross-react
with purified mMCP-4 and with several other proteases in
CTMCs.1 In the present study, polyclonal sheep anti-
mMCP-1 (Sh a-mMCP-1) detected mast cells in all sites,
including isolated peritoneal mast cells (data not shown)
and ear pinna (Figure 4K), which is in agreement with
previous findings.1 When Sh a-mMCP-1 antibody was
used for the immunohistochemical detection of mMCP-1
and other chymases in infected 2/2 and 1/1 jejunum,
the intensity of staining and the numbers of positive IM-
MCs in 1/1 jejunum were comparable with those ob-
tained with mAb RF 6.1 (Figures 3 and 4K). Significantly
fewer IMMCs were detected with Sh a-mMCP-1 in 2/2
infected jejunum than in 1/1 jejunum (P , 0.01 on days
8 and 10) (Figure 3), and the intensity of staining was
substantially reduced compared with that of IMMCs in
1/1 jejunum (Figure 4, G and H). Additionally, there was
a tendency for a higher proportion of 2/2 IMMCs to be
chymase positive than to be esterase positive (Figure 3).
These data are consistent with the RT-PCR results re-
ported below, suggesting that other chymases are
present in many of the IMMCs from infected 2/2 jejunum,
but that relative to 1/1 IMMCs, levels of expression are
low. This would be consistent with the possibility that
these residual chymases are in relatively low abundance
and/or they lack esterase activity.
Transcription of mMCP-2, -4, and -5 Is Normal
in mMCP-12/2 Mice
Oligonucleotide primers specific for the chymase genes
mMCP-2, mMCP-4, and mMCP-5 (Table 1) amplified
fragments of the expected size (800 to 900 bp) from 1/1
and 2/2 genomic DNA, the identity of which was con-
firmed by Southern blotting using gene-specific oligonu-
cleotide probes (data not shown), indicating that these
genes had not been disrupted by targeting events. The
transcription of these genes was investigated by RT-PCR
analysis.
Figure 8 shows the RT-PCR products from cDNA gen-
erated using total RNA samples from uninfected jejunum,
jejunum taken 8 days after infection with N. brasiliensis,
and ear pinna of mMCP-11/1 or mMCP-12/2 mice,
using primers for mMCP-1, -2, -4 and -5. The transcription
of each protease gene was assessed relative to the cor-
responding b-actin signal for each sample, and results
are shown in arbitrary units in Figure 9. The mMCP-1
transcript was undetectable in all samples from mMCP-
12/2 mice (Figures 8 and 9). In uninfected 1/1 jejunum,
mMCP-1 transcripts were detected at RNA concentra-
tions of 1 and 0.1 mg/ml but not at 10 ng/ml (Figures 8 and
9). On day 8 of infection, mMCP-1 transcripts were
readily detected at all three RNA concentrations in 1/1
jejunum. Transcription of mMCP-2 was substantially up-
regulated in jejunal samples from both mMCP-11/1 and
2/2 mice on day 8 of infection when compared with
lower levels in uninfected jejunum (Figures 8 and 9). Low
or negligible levels of transcription of the chymases
mMCP-4 and -5 were detected in jejunum from unin-
fected mMCP-11/1 and 2/2 mice, but, during infection,
there was upregulated jejunal transcription of both gene
products, although mMCP-4 transcripts appeared to be
Figure 7. Western blots demonstrating mMCP-1 and other chymases in 1/1
and 2/2 jejunum, respectively, and the absence of mMCP-1 in ear pinna. For
control purposes, 120 ng purified mMCP-1 (M1) was run simultaneously.
Blotting with sheep polyclonal anti-mMCP-1 (Pab) reveals bands in both
2/2 and 1/1 homogenates. The presence of mMCP-1 in 1/1 jejunal
homogenate (1/1 jej) and its absence from 2/2 jejunal homogenate (2/2
jej) are confirmed by using mAb RF 6.1 (Mab). The latter antibody fails to
detect any signal in homogenates from 1/1 (1/1 ear) and 2/2 (2/2 ear)
ear pinnae. All homogenates were from day 8 postinfection, and 30 mg of
protein was run in each lane.
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more abundant (Figures 8 and 9). In the ear pinna, nei-
ther mMCP-1 nor mMCP-2 was detectable by RT-PCR,
and this contrasted with the abundant mMCP-4 and
mMCP-5 transcripts from the same samples (Figures 8
and 9). Transcripts of both SCF and carboxypeptidase A
were readily detected in jejunal RNA from infected
mMCP-11/1 and mMCP-12/2 mice, but whereas SCF
(expressed in epithelial cells)26 was also detected in
uninfected jejunal samples from mMCP-11/1 and
mMCP-12/2 mice, carboxypeptidase A transcription
was negligible (data not shown). In conclusion, therefore,
the lack of any detectable mMCP-1 transcripts in the
mMCP-12/2 mice and the apparently normal transcrip-
tion of three other chymases known to be expressed in
the gut3 in these same mice are further evidence that the
targeted disruption of the mMCP-1 gene has been highly
selective.
CTMCs in 2/2 Mice Are Phenotypically Normal
In addition to the transcriptional data shown in Figures 8
and 9 that suggest that mMCP-4 and -5 are normally
present and that mMCP-1 is not transcribed in the ear
pinna, many CTMCs in the ear pinna were stained with Sh
a-mMCP-1 but not with mAb RF 6.1 (Figure 4, K and L).
Cell counts after staining the sections with toluidine blue
(Figure 4I) revealed 61.2 6 5.8 and 69.4 6 6.4 CTMCs/
mm2, and, using esterase staining, the cells were in-
tensely stained (Figure 4J) and the counts were 59.2 6
6.2 and 75.1 6 7.9 CTMCs/mm2 in the ear pinnae from
1/1 (n 5 9) and 2/2 mice (n 5 10), respectively, on day
8 of infection. The cells had typical mast cell morphology
(Figure 4), and there were no obvious differences in
granule staining intensity between 1/1 and 2/2 CTMCs.
Peritoneal cells were harvested from uninfected 1/1 (n 5
5) and 2/2 mice (n 5 5), and yields were 5.4 6 0.6 3 106
and 5.1 6 0.9 3 106 cells, respectively. The percentage
mast cell counts were comparable (1.5 6 0.2% versus
1.5 6 0.4%) in Leishman’s-stained and in esterase-
stained cytospins (1.1 6 0.1% versus 1.2 6 0.3%). Again
there was no difference in the intensity of esterase stain-
ing, which was as strong as that observed in the ear
pinna. These data show that targeting the mMCP-1 gene
has no obvious effect on mast cells in the connective
tissues and serosae.
Discussion
The aim of this study was to characterize the IMMCs in
mice lacking the b-chymase mMCP-1. The abundance of
IMMCs in nematode-infected intestine1–3 and the associ-
ated accumulation and secretion of the highly soluble
b-chymases in rodents4,12,17 are strongly indicative of a
major function for these proteases. It is clear from this
study that there are structural differences in the granule
matrices of IMMCs in null mice, and that there are sub-
stantial histochemical and immunohistochemical differ-
ences from their 1/1 counterparts. There are also signif-
icant kinetic differences in the accumulation of IMMCs
with fewer IMMCs on day 8 and more on day 10 of
infection in 2/2 when compared with 1/1 jejunum.
The targeting of the mMCP-1 gene was shown to be
specific by genomic analysis, and this was further con-
firmed by the absence of mMCP-1 transcripts in both
uninfected and parasitized mMCP-12/2 mice. These ge-
netic data were strongly supported by the immunohisto-
chemistry and immunoassay of mature mMCP-1 protein,
which was completely undetectable in 2/2 jejunal tissue.
In conclusion, the genetic and tissue analyses provide
convincing evidence that the mMCP-1 gene has been
specifically targeted.
Because the mMCP-1 gene is located within a cluster
of mast cell- and T-cell-specific protease genes on chro-
mosome 14,30 we confirmed that transcription of
mMCP-2 and -5, in the 850-kb gene cluster, and of
mMCP-4, which is also on chromosome 14,30 was unaf-
fected by the targeting events. For example, mMCP-2
was transcribed at low levels in the uninfected intestine,
with transcripts appearing more abundant in parasitized
gut. The levels of expression of mMCP-2 in 2/2 mice was
comparable with the levels seen in the 1/1 mice. It was
clear that CTMCs in the ear pinnae of 2/2 and 1/1 mice
expressed mMCP-4 and -5, but not mMCP-1 or -2. This
Figure 8. PCR products from RNA samples reverse transcribed and amplified by PCR. Initial dilutions of the RNA template before RT are indicated (1, 0.1, and
0.01 mg/20 ml reaction volumes). Primer sets used for PCR were specific for mMCP-1, mMCP-2, mMCP-4, mMCP-5, and b-actin as indicated. Jejunal samples were
from uninfected mMCP-11/1 and mMCP-12/2 mice (top two panels) , N. brasiliensis-infected mMCP-11/1 and mMCP-12/2 mice (8 days postinfection)
(center two panels), and ear pinna of N. brasiliensis-infected mMCP-11/1 and mMCP-12/2 mice (bottom two panels).
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pattern is consistent with that seen in BALB/c mice, in
which transcription of mMCP-2 and the presence of ma-
ture mMCP-2 protein has been described in the gut but
not in CTMCs.31 Some other strains of mice, including the
WBB6 F1/J, express mMCP-2 in some CTMCs,
31 but
mMCP-1 appears not to be expressed in any tissues
other than those associated with mucosal surfaces,17
and in almost every report the mMCP-1-positive mast
cells were predominantly intraepithelial.1,3,17 The levels
of expression of mMCP-4 and -5 in normal and parasit-
ized gut appeared to be lower than that of mMCP-2 but
were apparently unaffected by the disruption of the
mMCP-1 gene. These semiquantitative analyses of gene
transcription indicate that the other major chymases in
IMMCs and CTMCs are expressed normally in the mutant
mice and further confirm the specificity of the targeting
event.
Light microscopy suggested that IMMCs in 2/2 mice
had smaller, less intensely toluidine blue-positive gran-
ules that often did not stain for esterase and were poorly
immunostained by polyclonal anti-mMCP-1 and not at all
with mAb RF 6.1. Ultrastructural analysis established that
the classical paracrystalline structures, described in IM-
MCs from mice2,3 and rats32 and clearly present in 1/1
IMMCs, were completely absent from 2/2 IMMCs. In-
stead, new structural features in the granule matrices and
a more rounded as opposed to a stellate appearance of
the granules predominated. The fact that the granules
remained toluidine blue positive suggested that proteo-
glycans were still present. Importantly, the polyclonal
antibody detected proteins within the IMMCs consistent
with the molecular weights of mMCP-2, -4 and -5.20,33,34
It is not clear whether this polyclonal antibody, which was
affinity purified on mMCP-1-sepharose, reacts with
mMCP-2, but because it binds to CTMCs, which, in this
strain of mice, do not express mMCP-1 or -2,31 it probably
cross-reacts with mMCP-4 or -5. However, the transcrip-
tion studies suggest that neither of the latter proteases
are abundantly expressed in the jejunum, and this is
substantiated by the histochemical data showing low
levels of chloroacetate staining in 2/2 IMMCs.
The only previous quantitative analysis of IMMC gran-
ule ultrastructure in parasitized mice is consistent with
our observation that every intraepithelial IMMC contained
granules that were stellate or irregularly shaped because
of the presence of crystals.3 In parasitized rats, paracrys-
talline structures were identified in IMMCs at a time dur-
ing infection when there was histochemical evidence of
depletion of proteoglycan and monoamines from the
granules.32,35 In both rat and mouse, the concept that
IMMCs were activated and releasing granule products
was confirmed by showing that the release of rMCP-II
and of mMCP-1 both systemically and into the gut lumen
was maximal 6 to 10 days after infection, a time when
peak numbers of IMMCs were both intraepithelial and
their granules contained crystals.32,35,36 It is tempting to
suggest that both of these chymases are sufficiently con-
centrated in the granules to form crystals, and that crystal
formation could be facilitated by the loss of other granule
matrix constituents such as chondroitin sulfate. We have
shown previously, for example, that the release of glycos-
aminoglycans into rat plasma is significantly correlated
with levels of rMCP-II during systemic anaphylactic
shock,37 and the diminishing levels of chloroacetate and
proteoglycan staining in rat IMMCs in the jejunum were
Figure 9. Histograms showing the results of densitometric analysis of pro-
tease gene transcription as measured by RT-PCR (see Figure 8). The data
show the intensity of each PCR product recorded as a proportion of the
corresponding b-actin control PCR product from the same sample, to elim-
inate variations in the heparinase/RT reactions that could affect the efficiency
of subsequent PCR reactions. Graphs are shown to summarize the data from
RNA samples from uninfected mMCP-11/1 and mMCP-12/2 mice (n 5 4)
(A) and from N. brasiliensis-infected mMCP-11/1 and mMCP-12/2 mice
(n 5 5) (B), and ear pinna from N. brasiliensis-infected mMCP-11/1 and
mMCP-12/2 mice (n 5 4) (C). Initial dilutions of the RNA template before
RT are indicated (1, 0.1, and 0.01 mg/20 ml reaction volume).
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also highly correlated,37 indicating that IMMCs were be-
ing substantially depleted. This suggests that both pro-
teoglycan and protease diffuse rapidly out of, and away
from, the cell, unlike heparin/rMCP-I or heparin/tryptase
complexes.38,39 Three-dimensional modeling of mMCP-1,
-2, -4, and -5 suggests that mMCP-1 and -2 lack one of the
two clusters of basic residues present on mMCP-4 and -5
and that the remaining cluster has a relatively low charge
density.38 The two regions predicted to have a strong elec-
trostatic potential on mMCP-4 and -5 are thought to contrib-
ute to the binding of these highly cationic proteases to
heparin38 in CTMCs. Because IMMCs lack heparin,4,6,36 the
high concentrations of b-chymases (;100 to 150 pg rMCP-
II/cell),36 may be sufficient, when conditions are right, for
crystals to form. It is reasonable to hypothesize, therefore,
that the absence of crystals in 2/2 IMMCs is the direct
consequence of the absence of mMCP-1.
Given that, apart from mMCP-1, protease expression in
IMMCs was likely to be normal, one of the most surprising
differences between targeted and control mice was
the substantial diminution of esterase activity in the 2/2
IMMCs. This was most obvious in parasitized mice in
which mast cells were so abundant that there was no
difficulty in recognizing these very striking histochemical
differences. However, there was very intense esterase
staining of CTMCs and of serosal mast cell granules that
do not express mMCP-1, and although the lack of
mMCP-1 in the 2/2 IMMCs may account for the dimin-
ished esterase staining in the gut, it is also possible that
mMCP-2 contributes little to the esterase activity and that
the concentrations of mMCP-4 and -5 are too low to
generate strong esterase activity. An alternative possibil-
ity, given the structural differences in the granules, is that
the stacking of the proteases on the glycosaminoglycan
side chains38 is disrupted and that the proteases are
either nonfunctional or are catabolized in the granules.
The most likely explanation, however, given the rather
weak immunostaining of IMMCs with polyclonal Sh
a-mMCP-1 is that, apart from mMCP-1, the chymases in
IMMC granules are in low abundance.
The time frame of this study, focusing on the early mast
cell response rather than the resolution of the response
several weeks later, does not allow us to distinguish the
different mast cell phenotypes described by Friend et al,3
and it would be interesting to determine whether, during
this phase of resolution, the 2/2 IMMC phenotypes vary
in the same way as their 1/1 counterparts. Transcripts of
mMC-CPA were detected in jejunal RNA from 2/2 and
1/1 mice, which correlates with recent observations that
IMMCs in parasitized mice express mMC-CPA,27 al-
though no attempts were made to quantify these tran-
scripts in this study, nor were appropriate antibodies
available to determine whether the mature protein was
equally abundant in 2/2 and 1/1 groups of mice.
The differences in IMMC kinetics in 2/2 and 1/1
jejunum are potentially of greatest interest but must be
interpreted with considerable caution at this stage, be-
cause all of the 1/1 controls were random-bred wild-type
MF-1, which, although matched for age and sex, were
genetically distinct from the 2/2 MF-1/S-129-null mice.
However, we obtained similar results in a pilot experiment
carried out using mMCP-11/1 and 2/2 littermates from
a heterozygote cross. On day 10 of N. brasiliensis infec-
tion, esterase-positive IMMCs were less abundant and
less intensely stained in the 2/2 mice compared with
their 1/1 littermates. Most studies in mast cell-deficient
mice suggest that IMMCs have relatively little influence
on the immunological expulsion of N. brasiliensis, and the
findings reported here show relatively minor (twofold)
differences in worm burdens between the two groups on
day 8 of infection. The question may be resolved more
readily in current studies with 2/2 and 1/1 littermates
infected with Strongyloides ratti or Trichinella spiralis, in
which there is stronger evidence of IMMC involvement in
the immunological rejection of both parasites.11,40,41
Although the differences in cell kinetics could be due
to the variable levels of infection and to background gene
differences, the absence of mMCP-1 could directly affect
the turnover of IMMCs. For example, it has been shown in
sheep that IMMCs escape onto the mucosal surface,42
and although it is probable that intraepithelial mast cells
will, like mature enterocytes, be shed as they migrate up
the villus column, they could also escape through the
tight junctions if, as our previous studies with rMCP-II
using ex vivo perfusion suggest,12 b-chymases perme-
abilize enterocyte tight junctions. One of our long-term
aims in deleting mMCP-1 is to test in vivo the hypothesis
that b-chymases contribute to the immunological expul-
sion of nematodes by promoting the pathotopic transfer
of immunoglobulins from the mucosa into the lumen of the
gut. The present results, showing that there is robust
IMMC recruitment in the absence of mMCP-1, suggest
that it will be feasible to determine the contribution of
these abundant proteases to the intestinal pathology as-
sociated with nematode infection.
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